Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-28T00:31:38.389Z Has data issue: false hasContentIssue false
  • English
  • Français

Differences in Hospital-Associated Multidrug-Resistant Organisms and Clostridium difficile Rates Using 2-Day versus 3-Day Definitions

Published online by Cambridge University Press:  10 May 2016

Adrijana Gombosev ,
Salah E. Fouad ,
Eric Cui ,
Chenghua Cao ,
Leah Terpstra ,
Taliser R. Avery ,
Diane Kim ,
Hildy Meyers ,
Michele Cheung  and
Susan S. Huang
Adrijana Gombosev*
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Salah E. Fouad
Affiliation:
Infection Prevention Program, Saddleback Memorial Medical Center, Laguna Hills, California
Eric Cui
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Chenghua Cao
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Leah Terpstra
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Taliser R. Avery
Affiliation:
Department of Population Medicine, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts
Diane Kim
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
Hildy Meyers
Affiliation:
Disease Control and Epidemiology, Orange County Health Care Agency, Santa Ana, California
Michele Cheung
Affiliation:
Disease Control and Epidemiology, Orange County Health Care Agency, Santa Ana, California
Susan S. Huang
Affiliation:
Division of Infectious Diseases and Health Policy Research Institute, University of California–Irvine Health, Irvine, California
*
University of California–Irvine School of Medicine, Health Policy Research Institute, 100 Theory, Suite 110, Irvine, CA 92617 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

We surveyed infection prevention programs in 16 hospitals for hospital-associated methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, extended-spectrum β-lactamase, and multidrug-resistant Acinetobacter acquisition, as well as hospital-associated MRSA bacteremia and Clostridium difficile infection based on defining events as occurring >2 days versus >3 days after admission. The former resulted in significantly higher median rates, ranging from 6.76% to 45.07% higher

Infect Control Hosp Epidemiol 2014;35(11):1417–1420

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 11 , November 2014 , pp. 1417 - 1420
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections. In: Olmsted, RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St Louis: Mosby; 1996:A-1–A-20.Google Scholar
2. Datta, R, Kuo King, M, Kim, D, et al. What is nosocomial? large variation in hospital choice of numerators and denominators affects rates of hospital-onset methicillin-resistant Staphylococcus aureus . Infect Control Hosp Epidemiol 2012;33(11):1166–1169.CrossRefGoogle ScholarPubMed
3. US Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. National hospital discharge survey 2010. March 2013. http://www.cdc.gov/nchs/nhds/nhds_tables.htm. Accessed March 22, 2013.Google Scholar
4. CDC. CDC HAI definitions: CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. January 2013. http://www.cdc.gov/nhsn/acute-care-hospital/index.html. Accessed February 21, 2013.Google Scholar
5. California Office of Statewide Health Planning and Development. http://www.oshpd.ca.gov. Accessed January 23, 2012.Google Scholar
6. Huang, SS. Healthcare associated infections: assessing the value and validity of our measures. Clin Infect Dis 2009;48(8):1116–1122.Google Scholar
7. Huang, SS, Rifas-Shiman, SL, Warren, DK, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007;195(3):330–338.Google Scholar
8. Huang, SS, Rifas-Shiman, SL, Pottinger, J, et al. Improving assessment of vancomycin resistant enterococci. J Infect Dis 2007;195(3):339–346.Google Scholar
9. Haley, VB, DiRienzo, AG, Lutterloh, EC, Stricof, RL. Quantifying sources of bias in National Healthcare Safety Network laboratory-identified Clostridium difficile infection rates. Infect Control Hosp Epidemiol 2014;35(1):1–7.CrossRefGoogle ScholarPubMed